MetLife Investment Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Buy |
44,442
+10,832
| +32% | +$70.4K | ﹤0.01% | 1979 |
|
|
2025
Q1 | $267K | Sell |
33,610
-638
| -2% | -$5.06K | ﹤0.01% | 2045 |
|
|
2024
Q4 | $434K | Buy |
34,248
+3,781
| +12% | +$47.9K | ﹤0.01% | 1882 |
|
|
2024
Q3 | $424K | Hold |
30,467
| – | – | ﹤0.01% | 1867 |
|
|
2024
Q2 | $420K | Sell |
30,467
-2,976
| -9% | -$41K | ﹤0.01% | 1825 |
|
|
2024
Q1 | $552K | Hold |
33,443
| – | – | ﹤0.01% | 1623 |
|
|
2023
Q4 | $488K | Hold |
33,443
| – | – | ﹤0.01% | 1693 |
|
|
2023
Q3 | $410K | Buy |
33,443
+7,037
| +27% | +$86.3K | ﹤0.01% | 1754 |
|
|
2023
Q2 | $315K | Buy |
26,406
+10,833
| +70% | +$129K | ﹤0.01% | 1979 |
|
|
2023
Q1 | $208K | Hold |
15,573
| – | – | ﹤0.01% | 2195 |
|
|
2022
Q4 | $335K | Hold |
15,573
| – | – | ﹤0.01% | 1898 |
|
|
2022
Q3 | $312K | Hold |
15,573
| – | – | ﹤0.01% | 1992 |
|
|
2022
Q2 | $279K | Hold |
15,573
| – | – | ﹤0.01% | 2068 |
|
|
2022
Q1 | $154K | Buy |
+15,573
| New | +$154K | ﹤0.01% | 2499 |
|
|
2021
Q4 | – | Sell |
-4,806
| Closed | -$114K | – | 2511 |
|
|
2021
Q3 | $114K | Buy |
+4,806
| New | +$114K | ﹤0.01% | 2383 |
|